[{"Assets_0_Q2_USD":33409000000.0,"CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q2_USD":0.39,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.78,"Country":"United States","EarningsPerShareBasic_1_Q2_USD":0.56,"EarningsPerShareBasic_2_Q2_USD":1.51,"EarningsPerShareDiluted_1_Q2_USD":0.56,"EarningsPerShareDiluted_2_Q2_USD":1.5,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162365000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":2445000000.0,"NetIncomeLossConverted_1_Q2_USD":916000000.0,"NetIncomeLossConverted_2_Q2_USD":2490000000.0,"OfficialName":"Bristol-Myers Squibb Company Common Stock","RevenuesConverted_1_Q2_USD":5144000000.0,"RevenuesConverted_2_Q2_USD":10073000000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":14821000000.0,"StockholdersEquity_0_Q2_USD":14699000000.0,"Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":1650000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":1660000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1644000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1653000000.0,"filed":"20170727","footnote":"nan","form":"10-Q","fp":"Q2","fy":"2017.0","name":"BRISTOL MYERS SQUIBB CO","period":"20170630","qtrs":"0","uom":"USD"}]